1. Home
  2. ALMS vs OPFI Comparison

ALMS vs OPFI Comparison

Compare ALMS & OPFI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ALMS
  • OPFI
  • Stock Information
  • Founded
  • ALMS 2021
  • OPFI 2009
  • Country
  • ALMS United States
  • OPFI United States
  • Employees
  • ALMS N/A
  • OPFI N/A
  • Industry
  • ALMS
  • OPFI Finance: Consumer Services
  • Sector
  • ALMS
  • OPFI Finance
  • Exchange
  • ALMS NYSE
  • OPFI Nasdaq
  • Market Cap
  • ALMS 402.6M
  • OPFI 363.8M
  • IPO Year
  • ALMS 2024
  • OPFI N/A
  • Fundamental
  • Price
  • ALMS $2.86
  • OPFI $12.86
  • Analyst Decision
  • ALMS Strong Buy
  • OPFI Buy
  • Analyst Count
  • ALMS 7
  • OPFI 2
  • Target Price
  • ALMS $24.50
  • OPFI $11.75
  • AVG Volume (30 Days)
  • ALMS 1.1M
  • OPFI 1.4M
  • Earning Date
  • ALMS 08-12-2025
  • OPFI 08-06-2025
  • Dividend Yield
  • ALMS N/A
  • OPFI 1.95%
  • EPS Growth
  • ALMS N/A
  • OPFI N/A
  • EPS
  • ALMS N/A
  • OPFI N/A
  • Revenue
  • ALMS $17,389,000.00
  • OPFI $305,566,000.00
  • Revenue This Year
  • ALMS N/A
  • OPFI $112.80
  • Revenue Next Year
  • ALMS N/A
  • OPFI $9.34
  • P/E Ratio
  • ALMS N/A
  • OPFI N/A
  • Revenue Growth
  • ALMS N/A
  • OPFI 31.46
  • 52 Week Low
  • ALMS $2.81
  • OPFI $3.09
  • 52 Week High
  • ALMS $13.53
  • OPFI $17.73
  • Technical
  • Relative Strength Index (RSI)
  • ALMS N/A
  • OPFI 54.44
  • Support Level
  • ALMS N/A
  • OPFI $11.60
  • Resistance Level
  • ALMS N/A
  • OPFI $12.69
  • Average True Range (ATR)
  • ALMS 0.00
  • OPFI 0.69
  • MACD
  • ALMS 0.00
  • OPFI -0.22
  • Stochastic Oscillator
  • ALMS 0.00
  • OPFI 44.21

About ALMS ALUMIS INC

Alumis Inc is a clinical-stage biopharmaceutical company focused on identifying, acquiring, and accelerating the development and commercialization of transformative medicines for autoimmune disorders. The Company leverages its proprietary precision data analytics platform, biological insights, and a team of experts with deep experience in precision medicine drug discovery, development, and immunology, to create medicines that significantly improve the lives of patients by replacing broad immunosuppression with targeted therapies. Company pipeline includes: ESK-001, TYK2, A-OO5, IRF5.

About OPFI OppFi Inc.

OppFi Inc is a tech-enabled, mission-driven specialty finance platform that broadens the reach of community banks to extend credit access to everyday Americans. It recognizes revenue through finance charges on installment and SalaryTap contracts based on the interest method.

Share on Social Networks: